(Q61924336)
Statements
A Crossover Study to Evaluate the Efficacy and Safety of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus (English)
0 references
April 2007
0 references
May 2008
0 references
70
0 references
20 year
0 references